Partnership With KU Anam Hospital
Began research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
symyoo
Korea CRO Association Member
Qualified for full membership in Korea Clinical Trial CRO Association.
SMART TRIALS Research Center
Established SMART TRIALS center to research and facilitate new IT technologies for tomorrow’s medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
Partnership With Inje Clinical Trial Center
Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University
First Global Phase III Trial As Coordinating Center
Symyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any … First Global Phase III Trial As Coordinating Center
First Phase III Pivotal Trial
Symyoo expanded its business into a full scope CRO and began to operate a first phase III trial for premature ejaculation study. 심유는 Full scope CRO로 사업을 확장했으며, 조루증 치료제 연구를 위한 첫 번째 3상 임상시험 진행을 시작했습니다.
SYMYOO Founded
Dongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry’s clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups. 의학박사인 유동진 대표이사는 여러 글로벌 제약 및 바이오 스타트업에서 CEO와 Medical director로 성공적인 경력을 쌓은 후, 한국 바이오 산업의 신약개발을 지원하기 위해 CRO를 설립했습니다.